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AbstractThis paper describes the unexpected stereospecific formation of a novel 
anthracyclinone incorporating the unprecedented aromatic ring-fused bridgehead-
hydroxylated bicyclo[3.1.1]heptanol scaffold. 
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sulfonylhydrazone 
 
 The bicyclo[3.1.1]heptane ring system is a common structural element found 
in numerous monoterpene and sesquiterpene natural products. For instance, the pinane 
skeleton 1, containing a bicyclo[3.1.1]heptane ring with a gem-dimethyl bridge, is a 
common constituent of monoterpenes from the wood and leaf oils of many higher 
plants, particularly Coniferae, as well as some algae and insects.
1
 Closely related α-
pinene 2 is the most widely distributed monoterpene and is a major component of 
turpentine oil.
1 
Bicyclo[3.1.1]heptanes containing a fused aromatic ring (e.g. 
benzopinane 3) are not naturally occurring but reports of their synthesis and properties 
abound.
2-8
 Bicyclo[3.1.1]heptane derivatives functionalized with bridgehead oxygen 
atoms (e.g. bicyclo[3.1.1]heptan-1-ol 4) are known constituents of naturally occurring 
glycosides,
9 
as are their unsaturated derivatives containing double bonds within the 
six-membered ring.
10 
To our knowledge, however, bicyclo[3.1.1]heptanes bearing 
both a bridgehead-alcohol and a fused aromatic ring (e.g. 5) are a previously 
unreported class of compounds.  
 During the course of our synthetic efforts aimed at developing a practical route 
towards β-rhodomycinone 6 starting from daunomycin.HCl 8a, we identified an 
unexpected 4-membered ring closure that provided stereoselective access to 
anthracyclinone 7, the prototypical member of an unprecedented class of compounds 
bearing a bridgehead-hydroxylated bicyclo[3.1.1]heptanol with a fused aromatic ring. 
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 Our proposed route towards β-rhodomycinone 6 involved, (i) acid-catalyzed 
hydrolysis of the daunosamine sugar from daunomycin.HCl 8a;
11
 (ii) conversion of 
the aglycone (daunomycinone) 9 to its 13-benzenesulfonylhydrazone 10 followed by 
reduction to give the 13-deoxyanthracyclinone 11;
12
 (iii) demethylation of the 4-
methoxyl group of 11,
13 
and finally (iv) regio- and stereoselective benzylic 
hydroxylation at C10 with trimethylamine-N-oxide
14
 to afford 6. 
 Deglycosylation of daunomycin 8a proceeded smoothly under the conditions 
reported by Yoo et al.
11
 to afford 9 in 89% yield (lit. 98%). Walsh and Olson
12 
recently disclosed a method for preparing 13-deoxyanthracyclines wherein 
anthracycline 13-keto groups were converted to 13-arylsulfonylhydrazones which 
were subsequently reduced under acidic conditions with NaCNBH3 to the requisite 
methylene compounds. The 13-arylsulfonylhydrazones of doxorubicin 8b were 
obtained in good yields by reaction with various p-substituted (i.e. p-CH3, p-Cl, p-F, 
p-NO2) benzenesulfonylhydrazines in anhydrous methanol. For the aglycone 
daunomycinone 9, we found that conversion to its 13-benzenesulfonylhydrazone 10 
was, for solubility reasons, best carried out in anhydrous THF, wherein its reaction 
with benzenesulfonylhydrazine was quantitative (single spot by TLC; THF:petroleum 
spirit 1:1) after overnight stirring at rt (Scheme 1). 
1
H and 
13
C NMR spectra for 10 
(CDCl3) were complex and difficult to interpret, being consistent with a mixture of 
cis- and trans-benzenesulfonylhydrazones and perhaps different H-bonded 
conformational isomers (Scheme 2). 
 The crude benzenesulfonylhydrazone 10 was initially subjected to the 
reductive conditions reported by Walsh and Olsen
12 
(p-toluenesulfonic acid (TsOH) or 
pyridinium p-toluenesulfonate (PPTS) with NaCNBH3 in methanol at 60 
o
C). These 
reactions consistently provided multiple products by TLC analysis as well as 
unchanged 10, and showed no evidence by mass spectrometry (EIMS and +ve and -ve 
ion ESMS) for the formation of the desired product 11 (expected m/z = 384.1). ESMS 
(-ve ion) analysis for the crude reaction mixtures typically displayed a prominent peak 
at m/z = 365.2, corresponding to an M-H species 18 mass units lower than for 11. 
Lack of success with Walsh and Olsen’s conditions led us to explore the reduction 
using other combinations of hydride reagents (NaCNBH3, NaBH4, NaBH(OAc)3), 
acids (CH3CO2H, TsOH, PPTS) and solvents (MeOH, CH3CO2H, THF) at various 
temperatures, however, none of these reactions provided any trace of 11 and similarly 
showed multiple products and unreacted 10 by TLC analysis, as well as -ve ion ESMS 
spectra in which a peak at m/z = 365.2 (as before) was apparent. 
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Scheme 1. Reagents: (a) 0.2 N HCl, 90-95 
o
C, 89%;
11
 (b) NH2NHSO2Ph, THF, 18 h, 
25 
o
C, quant.; (c) NaCNBH3, TsOH, DMF, 15 min, 110 
o
C. 
 
 Using Maryanoff’s conditions for the reduction of tosylhydrazones to 
methylenes (i.e. NaCNBH3, TsOH, 1:1 DMF:sulfolane, 110 
o
C),
15 
we noted that (i) 10 
was completely consumed within 15 min and that a single new spot of higher Rf than 
10 was visible by TLC; (ii) the reaction mixtures prominently displayed the 
previously observed m/z = 365.2 peak in their -ve ion ESMS spectra. After 
purification by silica gel chromatography and comprehensive 2D-NMR 
characterization (DQF-COSY, HMQC, HMBC, and NOESY), it was clear that the 
product was not 11 but the novel anthracyclinone 7. 
 The yields of 7 under these conditions were consistently around 30% which 
seemed low considering the clean conversions that were observed from TLC analysis. 
It was subsequently apparent that the remaining mass corresponded to highly polar 
(presumably polymerized) material that could only be eluted using MeOH. Attempts 
to optimize the yield of 7 by varying the reaction conditions met with limited success; 
although it was determined that sulfolane could be omitted from the reaction without 
affecting the yield. The 7S,9R,13S absolute stereochemistry for 7 was unambiguously 
assigned based on the 7S,9S stereochemistry of its daunomycin precursor and from 
NOEs (Figure 1). 
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Figure 1. NOEs observed in the NOESY spectrum (500 MHz, 600 ms mixing time) 
of 7. 
 
 The generally accepted mechanism for the reduction of tosylhydrazones to 
methylenes under acidic conditions invokes an initial hydride attack on the sp
2
 carbon 
of a protonated tosylhydrazonium ion to generate the reduced tosylhydrazine 
derivative. Elimination of p-toluenesulfinic acid from the tosylhydrazine subsequently 
gives rise to a diazene intermediate which decomposes by losing N2 to afford the 
corresponding methylene compound (Equation 1).
16
 
R2C=NHNHTs
+
R2CHN=NHR2C=NNHTs
BH3CN
-
H+
R2CHNHNHTs
N2
R2CH2
Ts-
(1)
 
 An analogous mechanism for the formation of 7 from 10 can be postulated 
wherein the developing negative charge at C13 resulting from loss of N2 in the final 
step does not protonate to yield 11 but instead attacks C7. Under the acidic reaction 
conditions, the C7-OH could protonate to create a good benzylic leaving group which 
loses H2O following attack by C13 to yield 7. 
 Although reasonable, this mechanism is incomplete since it cannot account for 
the fact that only the 7S,9R,13S stereoisomer of 7 was formed in the reaction. The 
7S,9R stereochemistry would be predicted in 7 from the above mechanism based on 
the 7S,9S stereochemistry of the daunomycin.HCl 8a precursor. However, unless 
hydride reduction of the benzenesulfonylhydrazone 10 is stereospecific, with a 
hydride ion attacking the protonated benzenesulfonylhydrazonium ion from just one 
face, some of the 7S,9R,13R-epimer of 7 should also be observed. 
 The A-ring of daunomycinone 9 is known to prefer a conformation in which 
the two hydroxyl groups at C7 and C9 adopt a pseudo-diaxial orientation stabilized by 
an intramolecular 6-membered hydrogen bond (H-bond) ring (Scheme 2, 9).
17 
Similar 
conformations can be envisaged for the cis- and trans-isomers of 
benzenesulfonylhydrazone 10 (Scheme 2, cis-10a and trans-10a). However, 10 
presents additional H-bond donor and acceptor groups in its 
benzenesulfonylhydrazone moiety which could potentially compete with the C7-OH 
for H-bonding to C9-OH by forming 5- and 6-membered H-bond rings. These 
alternative H-bonded conformers could either retain the pseudo-diaxial orientation of 
the C7 and C9 alcohols (Scheme 2, not shown) or, alternatively, a ring-flip could 
occur to reposition the two alcohols in a pseudo-diequatorial orientation (Scheme 2, 
cis-10b and trans-10b). As mentioned previously, 
1
H and 
13
C NMR spectra for 10 
were extremely complex supporting the notion that 10 probably exists (in CDCl3) as 
an equilibrium mixture of a number of these isomers/conformers which interconvert 
slowly on the NMR timescale. 
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Scheme 2. Proposed mechanism for the stereospecific formation of 7S,9R,13S-7. 
 
 Protonation of cis-10b and trans-10b under acidic conditions would result in 
formation of the cis- and trans-benzenesulfonylhydrazonium ions cis-10c and trans-
10c. Models indicate that the Re faces of cis-10c and trans-10c are both significantly 
shielded from approaching nucleophiles by the axial hydrogen at C7. If cis-10c and 
trans-10c represent the predominant species present in the reaction, facially-selective 
hydride attack from their respective Si faces could produce a stereoselective reduction 
leading exclusively to the sulfonylhydrazine 10d, bearing R-stereochemistry at C13. 
Spontaneous elimination of PhSO2
-
 from 10d followed by N2 loss would then furnish 
7S,9R,13S-7 by the mechanism described above. 
 In addition to providing access to the novel anthracyclinone 7, it seems 
plausible that reduction of benzenesulfonylhydrazones with NaCNBH3 may represent 
a more generally useful method for accessing other compounds bearing the aromatic 
ring-fused bridgehead-hydroxylated bicyclo[3.1.1]heptanol scaffold. These studies are 
currently in progress and will be reported in due course. 
 
Supplimentary DataExperimental procedures for the preparation of compounds 7 
and 10 are provided along with full characterization data for 10. 
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